tiprankstipranks
Short Report: Bears reduce exposure to Kohl’s as stock momentum fizzles
PremiumThe FlyShort Report: Bears reduce exposure to Kohl’s as stock momentum fizzles
3M ago
Enliven announces proof of concept data from Phase 1 trial of ELVN-001
PremiumThe Fly
Enliven announces proof of concept data from Phase 1 trial of ELVN-001
3M ago
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
PremiumPress Releases
Enliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
3M ago
Enliven initiated with a Buy at Mizuho
PremiumThe FlyEnliven initiated with a Buy at Mizuho
3M ago
Enliven to share initial proof of concept data from ELVN-001 Phase 1 trial
PremiumThe Fly
Enliven to share initial proof of concept data from ELVN-001 Phase 1 trial
4M ago
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024
PremiumPress Releases
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024
4M ago
Enliven reports Q4 EPS (47c), consensus (54c)
PremiumThe FlyEnliven reports Q4 EPS (47c), consensus (54c)
4M ago
Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
PremiumPress Releases
Enliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
4M ago
Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
PremiumPress Releases
Enliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100